August 4, 2025 · Form 4 insider transaction
Matsuda Masaru sold 6,330 shares of Arcutis Biotherapeutics, Inc. at $14.33 per share, a transaction worth $90.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.; The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.965 to $14.675, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.; Includes 1,095 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2025.